Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
AI
Tech
Science

Regeneron
Health
Sanofi
Mental Health
Cancer
Reproductive Health
Obesity
Topics

Advertisement

Advertisement

Regeneron

Share

Top Latest Popular

In the last 8 hours

Biohaven (BHVN), What Is Behind The Fresh Attention? Simply Wall St 20:08 Thu, 08 Oct

Tuesday

Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026 Regeneron Pharmaceuticals (Press Release) 12:01 Tue, 06 Oct

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies Sanofi (Press Release) 06:38 Tue, 06 Oct

Advertisement

Advertisement

Sunday

Experimental Regeneron Antibody Trevogrumab Cut Lean Mass Loss by About 42% in Semaglutide Users Over One Year Medical Daily 09:46 Sun, 04 Oct

In the last month

Regeneron’s Myostatin Inhibitor Preserves Muscle Mass In Phase II Obesity Study Scrip Pharma Intelligence 22:40 Fri, 02 Oct

EASD 2026: Regeneron’s muscle preserver shows benefit at lower doses Clinical Trials Arena 16:25 Fri, 02 Oct

Moderna stock rises 2% on Nasdaq 100 entry but this analyst says sell Invezz 11:46 Fri, 02 Oct

Sanofi And Regeneron Rekindle Their Alliance, But Will Magic Strike Again? Scrip Pharma Intelligence 22:46 Thu, 01 Oct

Sanofi to ‘ignite’ R&D in $8B deal with longstanding partner Regeneron BioWorld 21:10 Thu, 01 Oct

USPTO Director Issues Opinion Explaining Denial of Biocon Post-Grant Review Petition (PGR) Challenging EYLEA® Patent JD Supra 20:27 Thu, 01 Oct

Regeneron's Ubamatamab, Trevogrumab Show Strong Results In Cancer And Obesity Studies RTT News 19:55 Thu, 01 Oct

Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies WebWire 17:05 Thu, 01 Oct

Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC) Regeneron Pharmaceuticals (Press Release) 16:43 Thu, 01 Oct

Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss Regeneron Pharmaceuticals (Press Release) 16:32 Thu, 01 Oct

Advertisement

Upcoming Webinar Hosted by Xtalks: Inside Regeneron's Path to Scientific Intelligence and R&D Efficiency PR Newswire (Press Release) 13:35 Thu, 01 Oct

Sanofi forges new $8bn pact with Regeneron pharmaphorum 12:39 Thu, 01 Oct

Sanofi and Regeneron expand immunology partnership to the tune of $8bn Pharmaceutical Technology 12:13 Thu, 01 Oct

Regeneron, Sanofi Extend Dupixent Playbook With Four Next-Gen Immunology Antibodies Scrip Pharma Intelligence 09:31 Thu, 01 Oct

Sanofi, Regeneron expand partnership after Dupixent success STAT 07:26 Thu, 01 Oct

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies Regeneron Pharmaceuticals (Press Release) 06:02 Thu, 01 Oct

Moderna stock falls 6% in premarket: here's why Invezz 13:19 Wed, 30 Sep

Kodiak skyrockets on positive study data for 2 eye drugs BioPharma Dive 06:00 Tue, 29 Sep

Should You Buy Regeneron Pharmaceuticals Stock Before Oct. 30? The Motley Fool 18:26 Mon, 28 Sep

Regeneron Eylea Feels the Pinch as Kodiak Advances Extended Dosing for Eye Drug Benzinga 16:18 Mon, 28 Sep

Kodiak Sciences Says Eye Drug on Par with Regeneron's Medicine Benzinga 15:07 Mon, 28 Sep

Biohaven's Clinical Data on Bhv-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the Eortc-NCI-Aacr Symposium 2026 PR Newswire (Press Release) 12:37 Mon, 28 Sep

Irish YSTE winner wins major prize at EU science competition Silicon Republic 09:18 Mon, 28 Sep

Mirum’s Atebrioz, First Oral Approved For FOP, To Face Regeneron’s Pasatru Scrip Pharma Intelligence 23:23 Fri, 25 Sep

Biocon Loses Patent Challenge Bid as Squires Flexes Discretion Bloomberg Law 21:53 Fri, 25 Sep

Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026 Regeneron Pharmaceuticals (Press Release) 21:09 Thu, 24 Sep

Is Regeneron Stock a Bargain Below $800? The Motley Fool 20:40 Tue, 22 Sep

Regeneron Investors Can't Use FCA Action To Support Suit Law360 22:32 Mon, 21 Sep

Regeneron Beats Investor Suit Over Medicare Drug Price Reporting Bloomberg Law 19:40 Mon, 21 Sep

Paroxysmal Nocturnal Hemoglobinuria Market Forecast Upto 2036: 5 Emerging Therapies Poised to Accelerate Market Growth | DelveInsight PR Newswire (Press Release) 15:36 Thu, 17 Sep

Meet Aditya Sengupta, the 18-year-old Bellevue student who built an AI system to better predict dangerous clear-air turbulence; his research won $100,000 The Times of India 18:06 Tue, 15 Sep

Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool 14:11 Tue, 15 Sep

Spotlight On: Biosimilar Litigations - September 2026 JD Supra 20:29 Mon, 14 Sep

Class action deadline tonight: Faruqi & Faruqi, LLP Reminds Regeneron (Regn) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Business Wire (Press Release) 17:48 Mon, 14 Sep

Bispecifics Market to Gain Momentum During the Forecast Period (2026-2036) with Expanding Pipeline and Increasing Therapeutic Adoption | DelveInsight PR Newswire (Press Release) 15:37 Mon, 14 Sep

Regn Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law Business Wire (Press Release) 14:46 Mon, 14 Sep

Advertisement

Advertisement

Regeneron News

Latest news and updates on Regeneron Pharmaceuticals, an American biotechnology company that was founded in 1988. The company is listed on NASDAQ.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
Back to Lifestyle Health
- Cancer Cancer
- Infectious Diseases
- Mental Health
- Neurological Diseases
- Obesity Obesity
- Rare Diseases
- Reproductive Health